Condition

Metastatic Castration-Resistant Prostate Adenocarcinoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Measuring ctDNA to guide stopping 177Lu-PSMA-617 in metastatic prostate cancer

  This trial tests whether ctDNA tumor fraction can help decide when to stop 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07698535

• Combining lutetium‑177 PSMA therapy with sipuleucel‑T for advanced castration‑resistant prostate cancer

  This trial tests whether adding sipuleucel‑T to lutetium‑177 PSMA‑617 helps men with metastatic castration‑resistant prostate cancer.

  Recruiting Phase 1 City of Hope Medical Center · Duarte, California · NCT07219147

Related topics

Quick answers

How many Metastatic Castration-Resistant Prostate Adenocarcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →